封面
市场调查报告书
商品编码
1629749

尼古丁口香糖市场按类型、通路和地区划分

Nicotine Gum Market, By Type (2 mg, 4 mg, 6 mg), By Distribution Channel (Supermarkets, Hypermarkets, Pharmacies, Online Stores), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2024 年全球尼古丁口香糖市场价值将达到 19 亿美元,预计 2031 年将达到 31 亿美元,2024 年至 2031 年的复合年增长率为 7.2%。

报告范围 报告详细信息
基准年 2023 2024 年的市场规模 19亿美元
效能资料 2019 年至 2023 年 预测期 2024 年至 2031 年
预测期间 2024 年至 2031 年复合年增长率: 7.20% 2031 年价值预测 31亿美元
图。
尼古丁口香糖市场-IMG1

尼古丁口香糖是一种药用口香糖,可向身体输送尼古丁,并可作为戒烟辅助剂。尼古丁口香糖的作用是,当你咀嚼它时,它会在你的血液中释放少量尼古丁。这满足了使用者对尼古丁的渴求,并减少了戒烟时出现的戒断症状。越来越多的人试图戒烟,推动了全球尼古丁口香糖市场的发展。此外,人们越来越意识到吸烟的健康危害以及尼古丁口香糖在戒烟方面的益处,这也推动了全球对尼古丁口香糖产品的需求。然而,有关尼古丁口香糖销售和使用的严格规定可能会阻碍未来几年的市场成长。

市场动态:

全球尼古丁口香糖市场的发展受到多种因素的推动,例如越来越多的吸烟者想要戒烟,人们对吸烟健康问题的认识不断提高,以及口香糖作为烟草替代品的流行和接受度不断提高。然而,有关尼古丁口香糖产品销售和行销的严格规定限制了市场的成长。此外,创新尼古丁输送方法和替代戒烟产品的推出对传统尼古丁口香糖构成了威胁。领先的公司正在投资研发,以开发技术先进的尼古丁口香糖配方,以提高有效性和便利性。预计这将在不久的将来为市场参与者带来丰厚的利润机会。

本研究的主要特点

本报告对全球尼古丁口香糖市场进行了详细分析,并以 2023 年为基准年,给出了预测期(2024-2031 年)的市场规模和年复合成长率(CAGR%)。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球尼古丁口香糖市场的主要企业根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行分析。

主要公司包括葛兰素史克公司、强生公司、诺华消费保健品、ITC 有限公司、西普拉健康有限公司、百利高公司、Fertin Pharma、Alchem International、Revolymer、英美烟草公司和菲利普莫里斯国际公司。

本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球尼古丁口香糖市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过分析全球尼古丁口香糖市场所使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • PORTER 分析
  • 併购情景
  • 产业趋势

4. 尼古丁口香糖市集(依类型),2024 年至 2031 年

  • 2mg
  • 4mg
  • 6mg

5. 尼古丁口香糖市场,依通路,2024-2031 年

  • 超级市场
  • 大卖场
  • 药局
  • 网路商店

6. 尼古丁口香糖市集(按地区划分),2024 年至 2031 年

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第七章 竞争格局

  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Novartis Consumer Health
  • ITC Limited
  • Cipla Health Limited
  • Perrigo Company Plc
  • Fertin Pharma
  • Alchem International
  • Revolymer
  • British American Tobacco Plc
  • Philips Morris International Inc

第 8 章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第九章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7643

Global Nicotine Gum Market is estimated to be valued at USD 1.90 Bn in 2024 and is expected to reach USD 3.10 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 1.90 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.20% 2031 Value Projection: US$ 3.10 Bn
Figure. Nicotine Gum Market Share (%), By Region 2024
Nicotine Gum Market - IMG1

Nicotine gum is a medicated chewing gum that delivers nicotine to the body and is used as an aid to quit smoking. Nicotine gum works by releasing small doses of nicotine into the bloodstream when chewed. This satisfies the nicotine cravings of the user and reduces the withdrawal symptoms experienced when quitting smoking. The global nicotine gum market is driven by the growing number of individuals attempting to quit the smoking habit. Furthermore, the rising awareness about the health hazards of smoking and the benefits of nicotine gum in cessation is also fueling the demand for nicotine gum products worldwide. However, stringent regulations pertaining to the sale and use of nicotine gum may hinder the market growth in the coming years.

Market Dynamics:

The global nicotine gum market is driven by factors such as the increasing number of smokers wanting to quit smoking, growing awareness about the health issues of smoking, and wider availability and acceptance of chewing gum as an alternative to cigarettes. However, strict regulations regarding the sale and marketing of nicotine gum products restrain the growth of the market. Furthermore, the introduction of innovative nicotine delivery methods and alternative smoking cessation products pose a threat to convention nicotine gums. Major players are investing in R&D to develop technologically advanced nicotine gum formulations for better effectiveness and convenience. This is expected to present lucrative opportunities for market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global nicotine gum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global nicotine gum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include GlaxoSmithKline plc , Johnson & Johnson, Novartis Consumer Health , ITC Limited , Cipla Health Limited, Perrigo Company Plc, Fertin Pharma, Alchem International, Revolymer, British American Tobacco Plc, and Philips Morris International Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global nicotine gum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nicotine gum market.

Market Segmentation

  • By Type Insights (Revenue, USD Bn, 2019 - 2031)
    • 2 mg
    • 4 mg
    • 6 mg
  • By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
    • Supermarkets
    • Hypermarkets
    • Pharmacies
    • Online Stores
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis Consumer Health
    • ITC Limited
    • Cipla Health Limited
    • Perrigo Company Plc
    • Fertin Pharma
    • Alchem International
    • Revolymer
    • British American Tobacco Plc
    • Philips Morris International Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Nicotine Gum Market, By Type
    • Nicotine Gum Market, By Distribution Channel
    • Nicotine Gum Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Nicotine Gum Market, By Type, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • 2 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • 4 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • 6 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Nicotine Gum Market, By Distribution Channel, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Supermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Nicotine Gum Market, By Region, 2024 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • GlaxoSmithKline plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis Consumer Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ITC Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Health Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Perrigo Company Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fertin Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alchem International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Revolymer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • British American Tobacco Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Morris International Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us